相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Development of immune checkpoint therapy for cancer
Jill M. Fritz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function
Selena Vigano et al.
FRONTIERS IN IMMUNOLOGY (2019)
Inhibition of the adenosine A2a receptor modulates expression of T cell coinhibitory receptors and improves effector function for enhanced checkpoint blockade and ACT in murine cancer models
Robert D. Leone et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
A2A Adenosine Receptor Gene Deletion or Synthetic A2A Antagonist Liberate Tumor-Reactive CD8+ T Cells from Tumor-Induced Immunosuppression
Jorgen Kjaergaard et al.
JOURNAL OF IMMUNOLOGY (2018)
Sensitive and frequent identification of high avidity neo-epitope specific CD8+ T cells in immunotherapy-naive ovarian cancer
Sara Bobisse et al.
NATURE COMMUNICATIONS (2018)
A2AR Antagonism with CPI-444 Induces Antitumor Responses and Augments Efficacy to Anti-PD-(L)1 and Anti-CTLA-4 in Preclinical Models
Stephen B. Willingham et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Clinical significance of CD73 in triple-negative breast cancer: multiplex analysis of a phase III clinical trial
L. Buisseret et al.
ANNALS OF ONCOLOGY (2018)
The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets
Bertrand Allard et al.
IMMUNOLOGICAL REVIEWS (2017)
Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy
Paul A. Beavis et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Blockade of adenosine A2A receptor enhances CD8+ T cells response and decreases regulatory T cells in head and neck squamous cell carcinoma
Si-Rui Ma et al.
MOLECULAR CANCER (2017)
A Novel Antagonist of the Immune Checkpoint Protein Adenosine A2a Receptor Restores Tumor-Infiltrating Lymphocyte Activity in the Context of the Tumor Microenvironment
Melanie Mediavilla-Varela et al.
NEOPLASIA (2017)
Targeting immunosuppressive adenosine in cancer (vol 17, pg 709, 2017)
Dipti Vijayan et al.
NATURE REVIEWS CANCER (2017)
Metabolic reprograming of anti-tumor immunity
Madhusudhanan Sukumar et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
Co-inhibition of CD73 and A2AR Adenosine Signaling Improves Anti-tumor Immune Responses
Arabella Young et al.
CANCER CELL (2016)
Adenosine 2B Receptor Expression on Cancer Cells Promotes Metastasis
Deepak Mittal et al.
CANCER RESEARCH (2016)
A2A adenosine receptor antagonists to weaken the hypoxia-HIF-1α driven immunosuppression and improve immunotherapies of cancer
Stephen M. Hatfield et al.
CURRENT OPINION IN PHARMACOLOGY (2016)
Emerging concepts of T cell metabolism as a target of immunotherapy
Chih-Hao Chang et al.
NATURE IMMUNOLOGY (2016)
Molecular Mechanisms for cAMP-Mediated immunoregulationin T cells - Role of Anchored Protein Kinase A Signaling Units
Vanessa L. Wehbi et al.
FRONTIERS IN IMMUNOLOGY (2016)
Modulation of mTOR Signalling Triggers the Formation of Stem Cell-like Memory T Cells
Godehard Scholz et al.
EBIOMEDICINE (2016)
Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses
Ping-Chih Ho et al.
CELL (2015)
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chih-Hao Chang et al.
CELL (2015)
mTOR and differential activation of mitochondria orchestrate neutrophil chemotaxis
Yi Bao et al.
JOURNAL OF CELL BIOLOGY (2015)
Adenosine A2A Receptors Intrinsically Regulate CD8+ T Cells in the Tumor Microenvironment
Caglar Cekic et al.
CANCER RESEARCH (2014)
High-throughput detection of miRNAs and gene-specific mRNA at the single-cell level by flow cytometry
Filippos Porichis et al.
NATURE COMMUNICATIONS (2014)
Human memory T cells: generation, compartmentalization and homeostasis
Donna L. Farber et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Extracellular adenosine regulates naive T cell development and peripheral maintenance
Caglar Cekic et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Rapid effector function of memory CD8+ T cells requires an immediate-early glycolytic switch
Patrick M. Gubser et al.
NATURE IMMUNOLOGY (2013)
Rapid Perturbation in Viremia Levels Drives Increases in Functional Avidity of HIV-specific CD8 T Cells
Selena Vigano et al.
PLOS PATHOGENS (2013)
Receptor desensitization and blockade of the suppressive effects of prostaglandin E-2 and adenosine on the cytotoxic activity of human melanoma-infiltrating T lymphocytes
Yunyun Su et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
cAMP inhibits mammalian target of rapamycin complex-1 and-2 (mTORC1 and 2) by promoting complex dissociation and inhibiting mTOR kinase activity
Jianling Xie et al.
CELLULAR SIGNALLING (2011)
Cancer Exosomes Express CD39 and CD73, Which Suppress T Cells through Adenosine Production
Aled Clayton et al.
JOURNAL OF IMMUNOLOGY (2011)
Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets
Ryan D. Michalek et al.
JOURNAL OF IMMUNOLOGY (2011)
High-Functional-Avidity Cytotoxic T Lymphocyte Responses to HLA-B-Restricted Gag-Derived Epitopes Associated with Relative HIV Control
Christoph T. Berger et al.
JOURNAL OF VIROLOGY (2011)
The Mammalian Target of Rapamycin: Linking T Cell Differentiation, Function, and Metabolism
Jonathan D. Powell et al.
IMMUNITY (2010)
The role of mTOR in memory CD8+T-cell differentiation
Koichi Araki et al.
IMMUNOLOGICAL REVIEWS (2010)
Cyclic AMP Controls mTOR through Regulation of the Dynamic Interaction between Rheb and Phosphodiesterase 4D
Hyun Wook Kim et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Arginase: an emerging key player in the mammalian immune system
Markus Munder
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Adenosine regulates CD8 T-cell priming by inhibition of membrane-proximal T-cell receptor signalling
Carsten Linnemann et al.
IMMUNOLOGY (2009)
Anergic T Cells Are Metabolically Anergic
Yan Zheng et al.
JOURNAL OF IMMUNOLOGY (2009)
The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation
Ralph J. DeBerardinis et al.
CELL METABOLISM (2008)
Glucose uptake is limiting in T cell activation and requires CD28-mediated akt-dependent and independent pathways
Sarah R. Jacobs et al.
JOURNAL OF IMMUNOLOGY (2008)
Inhibition of cytokine production and cytotoxic activity of human antimelanoma specific CD8+ and CD4+ T lymphocytes by adenosine-protein kinase a type I signaling
Tatiana Raskovalova et al.
CANCER RESEARCH (2007)
A role for mammalian target of rapamycin in regulating T cell activation versus anergy
Yan Zheng et al.
JOURNAL OF IMMUNOLOGY (2007)
Glucose availability regulates IFN-γ production and p70S6 kinase activation in CD8+ effector T cells
CM Cham et al.
JOURNAL OF IMMUNOLOGY (2005)
Adenosine receptors: G protein-mediated signalling and the role of accessory proteins
M Klinger et al.
CELLULAR SIGNALLING (2002)
分享论文
